Did you know?
- In all, India has reported more than 11 million corona virus infections, the highest number in the world after the United States, and about 156,000 deaths.
- In India, a total of 1.14 crore doses of corona vaccines were administered as on February 22, 2021, through 2,44,071 sessions
- So far, 10.7 million people have been vaccinated and 1400,000 have received the second dose of the Covishield vaccine.
- AstraZeneca together with its partner, the Serum Institute of India, plan to supply over 300 million doses of corona vaccine to 145 countries in the first half of 2021.
- Covishield is less expensive compared to the vaccines from Pfizer-BioNTech and Moderna, and it doesn't need to be stored in ultra-low temperatures.
- The vaccine candidate from Novavax, which Serum Institute is developing for the Indian market and other low- and middle-income countries, is expected to hit the market in the first half of 2021.
- Over the last two decades global burden of NASH (non-alcoholic steatohepatitis) has more than doubled – from 40 lakh prevalent cases in 1990 to 94 lakh cases in 2017.
- NAFLD (Non-Alcoholic Fatty Liver Disease) is emerging as an important cause of liver disease in India, prevalent in around 9-32% of the general population.
- Researchers have found NAFLD in 40-80% of people who have type 2 diabetes and in 30- 90% of people who are obese. Cardiovascular disease is the most common cause of death in NAFLD.
- The Ayushman Bharat programme has so far screened 838.39 lakh people for hypertension, 683.34 lakh for diabetes and 806.4 lakh for the three common forms of cancer through.
- Almost 65% of all vaccines manufactured in India and exported around the world come from Hyderabad. There is no cluster like Hyderabad's Genome Valley anywhere in the world.
- Glenmark has built strong capabilities in the area of respiratory medicine and is among the leading players in this therapy area across several markets globally.
- USFDA has since last year halted nearly all inspections of overseas drug manufacturing plants citing the spread of the corona virus pandemic, affecting new drug approvals.
- It is projected that by 2026, the new cancer cases in India annually would reach 0.93 million in male and 0.94 million in female patients.
